S2 E95: Rare Earth Separation Can Take 1,000 Stages. GlycoSurf Saw 5. | Ryan Stolley

Nov 19, 2026

Rare earth separation is where the supply chain gets stuck. Pulling the elements apart from each other can take hundreds, even a thousand stages to reach high-purity oxides. Ryan Stolley, Principal Chemist and Director of R&D at GlycoSurf (opens in a new tab), designs the molecules that do that separating, building them from sugar and fat. In this episode of the Rare Earth Exchanges Podcast, Dustin Olsen and Daniel O'Connor ask him why rare earths are so hard to pull apart, how GlycoSurf tunes its molecules, what is ready to deploy today, and what stands between his chemistry and commercial scale.

Why rare earth separation is the hardest step

Ryan's explanation starts with the periodic table. The rare earths sit in one block, and they behave almost the same chemically. Unlike metals such as nickel and iron, rare earths lack the distinct chemistry that makes a clean split easy. Rough splits, such as lights from heavies, are within reach. Separating individual elements means exploiting very narrow differences, and that is why the process stacks up so many stages. For background on the elements themselves, see Rare Earths 101.

  • Ryan says pulling rare earths out of ore is well-understood chemistry, already done at multi-ton scale worldwide as long as the ore is rich enough.
  • Ryan says a lot of new R&D, from new engineering to new chemicals, is going into the separation step.
  • China's head start comes from richer, shallower ores plus decades of separation know-how built into legacy plants.

How GlycoSurf tunes a sugar-and-fat molecule to grab specific metals

GlycoSurf's core products are rhamnolipids: molecules that bacteria make in nature, which GlycoSurf makes synthetically in the lab. Each has a sugar head that grabs metals and a fatty tail. By changing where the sugar attaches, which sugar is used, and the length and shape of the chain, the company can open or tighten the binding pocket to favor larger or smaller metal ions. It can also make the molecule foamier for ion flotation or greasier for extraction into an organic solvent. As Ryan put it, essentially what they have made is a soap.

  • Rare sugars at around $100 a kilogram do not work for mining, so GlycoSurf leans on cheap inputs like xylose, a wood sugar Ryan calls essentially free.
  • Ryan says these naturally derived fats and sugars break down, unlike legacy extractants built on branched hydrocarbons and organophosphates, which persist in the environment and can feed algal blooms.
  • The rhamnolipids were first tested on removing uranium from groundwater, and Ryan says they show their highest affinities for uranium.

As few as five stages, and the scale-up wall

Asked how many stages GlycoSurf's approach needs, Ryan was careful: the work is still in R&D, at small scale, but on the microscale they have seen good separations in as few as five. The bottleneck is scale. A ton of material for a trial that may not work costs far more than ten grams of molecule in a lab bubbler. Of the 50 to 100 products GlycoSurf had tested at the time of recording, Ryan estimates 10 to 15 could be deployed at large scale immediately, and the company is already working with a mining company to deploy directly into its systems. Oak Ridge has been attacking the same stage-count problem from another direction; hear that conversation in S2 E89.

Where GlycoSurf fits in new U.S. separation plants

Ryan expects industry to stay conservative: new plants will want performance data proven at scale before switching chemistry. GlycoSurf's pitch to solvent-extraction operators is two-sided. It can supply its own custom molecules, and it can make known, well-documented extractants where the IP allows. Ryan notes that some extractants are not made commercially in the United States, and some are made in China under export controls. He sees national lab collaborations and new funding for large-scale prove-outs as the way new chemistry gets proven at scale.

Training the next generation of chemists

Ryan is also Associate Director of the University of Utah's Science Research Initiative, which puts first-year science students into research labs. It started with 30 students in five groups and had 700 students at the time of recording, about 500 of whom were set to be placed in roughly 80 research groups, plus 16 postdocs. He says GlycoSurf has hired about five of his former students, and the program now reaches into the U's mining engineering program as well.

Key Takeaways

  • Rare earth separation is the hardest step because the elements are so chemically alike.
  • GlycoSurf tunes sugar-and-fat molecules to target specific metals and keeps input costs low enough for mining.
  • Early microscale work has shown good separations in as few as five stages; scaling up is the open problem.
  • Ryan estimates 10 to 15 of GlycoSurf's 50 to 100 tested products are ready for large-scale deployment now.
  • GlycoSurf can also make known extractants that are not produced commercially in the U.S., where IP allows.
  • The impediment right now, Ryan says, is production capacity: "I just need a factory and I can get you as much as you want."

FAQs

Why are rare earth elements so hard to separate?

Rare earths sit together in one block of the periodic table and have very similar charges, ionization potentials and chemical reactivity. Rough splits are possible, but isolating individual elements means exploiting very narrow chemical differences, which is why conventional processes need so many stages.

How many separation stages does GlycoSurf's approach need?

As few as five, at microscale. Ryan Stolley says GlycoSurf has seen good separations in five stages in early research and development, and scaling up to industrial volumes is the work still ahead.

What are GlycoSurf's extractants made of?

Its core molecules are synthetic rhamnolipids: a sugar head that binds metals attached to a fatty tail. GlycoSurf adjusts the sugar, its attachment point and the chain length to change which metals the molecule grabs and how it behaves in a process.

What is ion flotation?

Ion flotation uses a soap-like molecule that binds the target metal and floats it to the surface in a foam, where it can be skimmed off. Ryan describes it as a selective alternative to precipitation methods that need large volumes of water, acid and base.

Can GlycoSurf supply existing solvent-extraction plants?

Ryan says yes, in two ways: GlycoSurf can provide its own custom molecules, and it can make known extractants that are not made commercially in the United States where the IP allows.


Transcript

Expand to see full transcript...

Dustin Olsen (00:01)
Ryan, welcome to the show. We're excited to have you here. How are you doing?

Ryan Stolley (00:04)
I'm doing well. Thanks for having me.

Dustin Olsen (00:07)
Ryan, you work for a company called GlycoSurf, and in that company you are the principal chemist. Do I have that right?

Ryan Stolley (00:14)
That's correct. That's right. And I'm the director of the research and development.

Dustin Olsen (00:19)
That's amazing. So let's talk really quick. How long have you been at GlycoSurf and in a brief summary, what is GlycoSurf known for?

Ryan Stolley (00:32)
Yeah, so I've been there since it's about 2019, 2020, although I had done some consulting before with them. And so our biggest market is chemicals for rare earth extraction and separations technology. And so we also make soap, which is funny, we'll talk about this probably in the conversation. And so we split the two, but they overlap.

Dustin Olsen (00:58)
Very good. So that is kind of our main topic I think for this show is how GlycoSurf focuses on the extraction and the separation of rare earths. Because here on the show we talk about how that is the biggest bottleneck of the entire supply chain from mine to magnet is this process right here. And we would love to just unpack how GlycoSurf is doing it differently, and maybe using the soap to clean it all up. So let's start there. So GlycoSurf says mining and crude separation is the easy part, right? And we would agree in comparison. And conventional separation takes 100 to even 1,000 stages to reach high purity oxides.

Ryan Stolley (01:35)
Yes. Happy to talk about it.

Dustin Olsen (01:57)
So for someone who isn't a chemist, why is it so hard to pull neighboring rare earths apart?

Ryan Stolley (02:04)
It's a great question. So if you think about on the periodic table, right? So rare earths are on the bottom and then but what you don't realize is that's the truncated version of the periodic table, right? So that whole big chunk actually sits right in the middle. And so when you think about how the periodic table is organized, these are all very, very similar in their chemistries. And so, right, their ionization potentials are pretty similar, they all have very similar charges on them, they have very similar chemical reactivities, as opposed to some neighboring groups that you would see in the periodic table, say between say nickel and iron or palladium and I don't know, silver or something like this. Those have very distinct chemical properties and so they're much easier to facilitate separations in that way. But the rare earths, with the chemistries being very similar, again, now you're gonna be really, really, really difficult in the ways that you would need to separate them because of those similarities. So when you talked about thousands of stages, right, this is where it comes where you're gonna get some separations, right, in terms of the bigger, so maybe the lighters versus the heavier's, but then you're gonna need to really kind of fine-tune and dial in the specifics of the differences in those chemistries, which are pretty narrow.

Dustin Olsen (03:20)
And so because of the similarities, that's why we have so many stages, up to 1,000, which I've never heard that many stages to get these high purity oxides before. How many stages does the GlycoSurf model use?

Ryan Stolley (03:40)
Well, so we're still in research and development on this. And so what we have are small scale applications of these. And then so we have both our glycolipids that we can fine-tune, and now we're also working with known existing extractants and separation molecules, some of which are proprietary, some of which are well known in the literature. And so currently we've had some work on the microscale, and so we've seen good separations in as little as five, but further development on this we're still working on. In particular large scale up, right? So having the materials on hand to start doing things on industrial scale is a bit of a bottleneck from the R&D perspective.

Daniel O'Connor (04:26)
A question on that. It's a fascinating area that's not very well understood. On the life cycle of research and development, would you say the company is more in discovery phase, which is earlier stage, still scientifically discovering, or has it moved into full-blown research and development where you have a series of real hypotheses that you can test, making your way towards a commercial stage?

Ryan Stolley (05:00)
Well, yeah, so it's actually very product specific, right? So we have myriad products available. Some are very early stage, right? And so we're still playing, still trying to do some modeling, still really trying to do some of the initial R&D things. Others that we have, I mean, we have chemistry in hand, and if we can get large scale production factory, we could be pumping out thousands of liters of material ready to go. Some of these are tried and true and known. So it's a broad spectrum from everything in terms of we're doing custom syntheses. We still like doing a lot of collaboration with academic partners, et cetera, doing custom syntheses or working on other types of extraction I don't know, engineering. And so we're at a variety of stages and we really like to interact with a lot of people at a lot of these various stages as well. If you want something that's tried and true and you need a lot of it, call us. If you have an idea and you want us to make something and play around with it, call us. We can do that kind of stuff too.

Daniel O'Connor (05:56)
Let me ask that question in a different way. You're developing a portfolio of chemical based products. And out of that portfolio, how many are needed if we look at rare earths and both extraction and then separation, how many of your different products are, A, needed? And, B, which ones are ready today versus still in development, research and development.

Ryan Stolley (06:34)
Yeah, this is a great question. Of course all of us as chemists and business people, we would always like a gun that takes all that shoots everything. And so whether or not that's feasible is I don't know. I've been chemist a long time and there's not many single solutions to many problems. And so some of these, depending on again the terroir of say, are we taking it from old like mine leachate? Are we having it from byproduct of some other type of mining facilities? We have a lot of products that we can deploy immediately. We're working actually with a mining company on deploying it directly into their systems already. So offshoots on the SLU [unclear]. And so we can, I don't know, with the slurries that are coming through, they're actually real lifetime scenarios that are coming off. And we can do this on large scale. So we have an engineering setup on that. On others, we have collaborators that are working on like I was saying the mine leachate where they're micronizing the type of similar multi-component precipitation systems. Right. And so they'll need a different variety of chemicals. With that in particular project, we have stuff that's ready to go on large scale that can be deployed. On some of the others, we have some that we would like to test actually in these real life scenarios. And so I would say of let's say it's 50 to 100 different types of tested products, I'd say about 10 to 15 we could deploy quite large immediately. And then the rest are somewhere else in kind of the R&D morass.

Daniel O'Connor (08:06)
Got it. That's helpful. Could you walk us through at a high level the types of chemicals that are used for extraction of rare earths versus the types of chemicals that are used for separation of rare earths?

Ryan Stolley (08:22)
Yeah, so there's a variety of approaches and systems for that. Okay, so if we're looking at say an extraction type system, what you're looking at are metal chelants. So there's very common ones like P204, N235, variety of these that are well known in the literature as extractants. And again, it depends on the systems that they're operating on. So do they want to do, say, mixer settler types where you're gonna be pulling the rare earths into an organic phase, or are you gonna be looking at something like ion flotation, which is something that we work really heavily on. There's a variety of different products that work in those. And so it depends on the system that you want. And again, it also works on the terroir of the system. So if you have something that foams quite heavily, or if your pH is a little bit different, right, then the solution chemistries are going to behave a little bit different. And so you're going to need to kind of fine-tune some of these. A very common system that's used for some of these separations is just simple precipitation. So maybe you have your rare earth oxide mixtures you dissolve in an acidic solution. You've got a mixture of all kinds of different rare earths in there, maybe other metals. And you can adjust the pH just with say hydroxide or sulfuric acid until you're reaching a critical point in which you'll selectively precipitate or at least close to selectively as you can, one element or group of elements that you can't. And so for say separations from a bulk system, you can do this by just simple adjustments that are pH. But that, as you might imagine, has a large mass flow, right? Because you're gonna need a lot of water, you're gonna need a lot of acid, and you're gonna need a lot of base. If you want to do something that's more of a say a selective process like ion flotation, now it's just going to grab the things that you want, float it to the top, you scrape it off, and then you can collect your extract in those regards. And so again, there's a variety of systems that need chemical specificity or chemical fine-tuning, depending again on the systems that you're operating in. And so what we're trying to do is cover as much territory in that space as possible.

Daniel O'Connor (10:26)
So what I hear you saying is that a big part of this is very contextual to what the specific demands are of the project. And one issue with rare earth especially when it's in the ground and you do the first stages to extract it, it releases radioactivity.

Ryan Stolley (10:54)
It can, depending on, yeah.

Daniel O'Connor (10:54)
And thorium in many cases thorium and uranium. And have you thought about, because you have to process that away, especially in like an ionic clay situation where is one example where you're leaching, you're creating these ponds and you're leaching the material out. But then also in monazite and other harder rocks, mineral situations. So any experience or at least a theoretical understanding of that challenge?

Ryan Stolley (11:34)
Yeah, yeah, yeah. We think about this actually quite a bit and we're coming at this also from like a third angle of this, which is actually we're really looking at separations of radio materials, right? So whether they're actinides or other kinds of I don't know, even if it's like cesium or some other non rare earth or non actinide materials, because I think that some of the molecular tailoring that we're working on in this space could really actually be applied to these types of systems. Start thinking of radio medicine, et cetera. And so we're pursuing this quite heavily. We have our bread and butter products or rhamnolipids were initially tested on removing of uranium from groundwater systems. And actually we have the highest affinities for uranium in these cases. And so even if we're not using our materials for the separations or extractions of rare earth specifically, we can really, really pull out quite a lot of the uranium from these types of systems too. So this is something that one we're interested in too, we have the technologies for. Now as what we do with the extracted uranium. This becomes a little bit outside of our wheelhouse, right? We can grab it for you and then it's your problem. But I think I mean that's everybody's kicking the nuclear potato down the road.

Daniel O'Connor (12:46)
Yeah, I mean, to your credit, you're solving a big part of the problem but the next part of the problem exactly is how do you dispose of it and how do you or manage it, right? And there's at least one company in the United States that's licensed to do that here. Are you here in Utah? I know Brett's in Utah. Are you in Utah?

Ryan Stolley (13:06)
We're in Utah, yeah. Yeah, we're here in Utah and I'm currently in my office at the University of Utah.

Daniel O'Connor (13:14)
Excellent. Okay. So basically, what would you consider more difficult or challenging? The extraction of the material first or then the ongoing separation of the different elements?

Ryan Stolley (13:36)
Like most of my answers is gonna be nuanced, but I'd say on the top it would be the separations of it. Right. So the extraction, the general elemental extraction, this chemistry is pretty well known, right? And so we can do this. I mean we're doing this on multiton scale worldwide. And so a big part of that though is if you have enriched ores or if you do not. Right. So if you have ppb levels, I mean now your extraction becomes a huge problem, right? And so but the separations is something that is really difficult and that's where I think a lot of R&D is going into. And so that's where new and new methods, new engineering, new chemicals and everything, a lot of time is spent in thinking about how to design things for those types of systems. As the extractions, if it ain't broke, don't fix it and you can make these things on kiloton scale.

Daniel O'Connor (14:34)
Right, yeah. And to your point, probably well with the heavy rare earths about 98% of the heavy rare earths are separated in China. So for your company that's a very intriguing focus, right? Because the challenge with those is that they're not needed that often. But when they are needed, and they're actually not that expensive, all things being equal, but when they are needed, if you don't have them, you can shut down whole industries.

Ryan Stolley (15:13)
Absolutely right. Yeah. It's something we think about quite a bit. I mean, it's a bread and butter here, particularly as China has one, like very, very good ores for this, right? They're more surface located, they have really high concentrations, plus they've had decades to kind of build out that separations infrastructure. Right. And so even if you're doing it in say not the slickest or most efficient way, if you've now had like these legacy systems that have been built for decades, plus all that internal knowledge to get built from this, they have a considerable advantage. And now with us is not having as rich of ores, more disparate mining for these types of ores in different places. And so a lot of time spent looking for alternative sources for this. Plus then again, depending on where you are in the country, the lights versus heavies or the other types of ratios are gonna be all over the place.

Daniel O'Connor (16:08)
Right. Makes sense. Makes sense. Dustin.

Dustin Olsen (16:14)
Yeah. Ryan, I was curious if you could talk a bit about what's unique with GlycoSurf is you guys use sugar and how you use that to kind of fine tune the separation a little bit, right? So could you expand on that?

Ryan Stolley (16:30)
Yeah, yeah. Yeah. So I'll start with kind of the older fashion versions of these, which are gonna be longer chain. Typically they're branched, and you'll have organophosphates, something along this line. With these, I mean they're very good at what they do, but some of the issues is okay, so you have these branched long chain hydrocarbons, these persist in the environment for quite some time. All right, the branching creates metabolism issues in terms of breaking them down naturally. The organophosphates, one, phosphorus itself is a critical mineral, too. The other piece too is if these get into water systems, that's why you can end up with algal blooms. And so there's some serious environmental consequences for using these legacy chemicals. Ours are a natural product; they're synthesized by Pseudomonas bacteria. However, we make them synthetically in the lab and so for the chemists that are out there, we have beta hydroxy acids and there's a rhamnose sugar that's attached to it. And so this is a combination of naturally occurring fats that are easily broken down, and then we have sugars, which clearly can be broken down quite easily. And when you attach them in a specific way, what you create is a head, that can grab the metals and then you have your long chain. And so what we can do is we can tune the attachment points of where these sugars attach to the fat chain. We can modify the length of the chain or other types of branching, unsaturation, depending on natural abundance. So we can use naturally occurring oils, right, so these are bioderived, so these are not going to be, say, derived from oil or coal sources. The sugar, of course, is naturally derived. And then there's myriad sugars around too. So now what we can start thinking about is the geometry of the sugars and the hydroxyls that are on there in terms of how we can then build in and design different kinds of chelants depending on say now we were talking about the size difference between elements. Well now if I can open up that pocket a little better, am I gonna be grabbing the larger atomic radii versus if I constrict it, right then I might have a better selectivity for the smaller nuclei. Now so the other parts too is not all sugars cost the same and not all fats cost the same. And so now we can design molecules both on chelation ability but also on price. So if I'm looking at say like a more rare sugar where I'm looking at $100 a kilogram, that's not gonna be feasible for a mining type scenario, versus something like xylose, wood sugar, which is essentially free and it's like a byproduct from a variety of fermentation processes. And so now we can get, I don't know, a kiloton for $100 or something like this. And so we can modify the synthesis for any kinds of properties. Now we work a lot in ion flotation. So essentially what we've made is a soap. You got a polar head and a nonpolar tail. So they make micelles and they foam up. Well now what we can do is modify that chain to make it more or less foamy. Right? We can make it more or less hydrophobic, right? So if you want to work in say extraction into an organic solvent, now we can make it greasier and it'll get pulled up better. Or we can make it foamier or a variety of things like that.

Dustin Olsen (19:46)
You're making chemistry sound really cool. Yeah, it's truly incredible. Just fine-tuning it, as you're describing, things could become more foamy or more greasy, and that's really incredible. A follow-up question to some of this, mentioning the bio organics and things involved with this. We've had some other people on the show that also specialize in their own version of the biochemistry. But there's a limitation to how much they can produce or get because of the bio nature of that chemistry. Is that the same thing here with sugar? It sounds like you're getting sugar from a variety of different places and elements, but what does that look like?

Ryan Stolley (20:38)
Yeah, so I'll try to think about what you're talking about. If you think it's something like say lanmodulin or some of these others where these are very, very, very complex molecules and synthetically they're gonna be a little bit less accessible in terms of making them and having them efficient for what they're trying to do. Fermentation science is really well developed and understood, but still it's gonna be hard to extract and there's gonna be a lot of chemical processing that goes into this. Sugars are wildly abundant in nature. The variety of them that are available to us and the relative costs. I don't imagine we'll have the same types of issues 'cause even though this is a natural product initially, we are making them synthetically and so the materials are widely available and I don't see an issue on those. Again, like any other market, I don't wanna play my cards before I actually see what's going on. We are gonna be subject to price fluctuations across whatever global markets for these types of things, but I don't think they're nearly as volatile as other things.

Dustin Olsen (21:46)
Totally makes sense. Speaking of the market, I am curious with the technology and the process that you guys use at GlycoSurf, if the US were to build out a huge separation plant process in it to the end of the decade, would they be more attracted to what's tried and tested and true and all that, or would they be willing to adopt something like what GlycoSurf is doing to be more efficient or cost effective. Where do you guys see yourself being able to play in a bigger space?

Ryan Stolley (22:26)
This is a great question. I was just at a DOE workshop on exactly these types of questions. Right. I would say business typically, this shouldn't be a surprise to anybody, is pretty conservative, and you're right. So you can start making your metrics around performance data. And I think in order to become competitive with these, some of those tried and true, with large scale experimentations, replications, particularly like you say, at scale, it could be that's the main driver to start becoming competitive. Is just having that tried and true prove out. Now, the flip side of that is getting the opportunities to showcase these types of things can be it's a crapshoot really. Some companies are like we've had engagements with a company that I would not expect to want to try to do new things. But they're holding all kinds of meetings and workshops to try to deploy and use these on their new source of rare earth oxides. And so again it's just these conversations where you'll find people that are actually really into trying new things, either from a performance or through an ethical type scenario. And so really it's just trying to find the conversations of the people who want to try this stuff. And the other part of this too is in building collaborations with national labs, and there's now funding that's coming towards these kind of more large scale prove out, right? Because now, right, if we're running experiments in our lab and I have like 10 grams of our molecule and I do it in a bubbler, that's a relatively inexpensive experiment. But now if I need to have, I don't know, a ton of material just to go play with something, may or may not work. I may not get it back. That becomes quite an expensive experiment to do. I mean, this is why R&D funding at large corporations goes down because these things become expensive at scale.

Dustin Olsen (24:29)
Dan, did you have anything?

Ryan Stolley (24:31)
It looks like he's talking, I can't quite hear ya. Now I can hear you.

Daniel O'Connor (24:32)
Can you hear me? Okay. So it's really fascinating. So with what Dustin was saying, I mean, the US is in a sort of crisis right now. We call it the transition vulnerability window. It's the period of time between right now and when the United States can have industrial resilience when it comes to rare earth elements. So I think that they're, and you've sort of hinted to this, that companies are conservative and probably solvent extraction, the larger separation facilities that ramp up will probably be based on solvent extraction. So assuming that's the case, how can you add value to those companies, those separation facilities? How could they partner with your company? What could your company do for them?

Ryan Stolley (25:36)
Yeah. I mean we can provide our custom molecules, the ones right, that are bread and butter. But the other part of this too is some of the extractants are not made commercially in the United States. Some of these are known, right? And to the point of chemistry being cool, the universe is all the same thing and it's all made of the same things. And so if there's IP clearance on a lot of these things, we can make known and existing molecules, if they want them, right? And again, there are the legal connotations that go into this. So again, I'm not promising anything that we can't do legally, but I mean there are a lot of these that are very very well known and very known to be synthesized. The other part too is the way IP works in terms of is it a use case or is it the way that they make it, right? And so if we can make these in a clear way, we can provide things with stuff that they know how to do. Right. We're well equipped, engineering staff, chemistry staff, we can build out a lot of these molecules. And it's a blessing that many of the known extractants are fairly simple in that case. And so we can meet them at the R&D level if they want to try something new, or we can meet them at the pre existing known place and then we're happy to work with anybody on those types of chemical projects.

Daniel O'Connor (26:54)
What would be an example of a well known extractant that is involved with rare earth separation? Can you give us an example or two?

Ryan Stolley (27:05)
Yeah, so these typically have code names. So again we like stuff like P204, P507, N235, and so these are again just long chains. Some of them they have a variety of head groups on them. Some are phosphonic acids, some are diacids, some that are used in say remediating or separating say the actinides from the rare earths, right? And so I mean there's a whole smorgasbord of these. There's also say like the TODGA class of molecules. And so there's a variety of these and some of which are well explored. And then others there's a pretty cool open playing field where you can make other kinds of things that are very similar but not quite the same. CA-12 is another one and so there's a lot of these that are available and not to say that the ones I had mentioned were something that we can make here. Like I said, some IP is owned in the United States to make these. Some of these are made in China and there's export controls and so there's some limits on those types of things too.

Daniel O'Connor (28:21)
Yeah. That's right. I mean we know that China and it depends on what happens January 10 with these export licensing requirements, but China does control anything having to do with the rare earth element, mining or separation or metalization. They're not sharing the IP, they're being very careful. So in that area, are you familiar with any of the products, chemical based products that they make that they control that we don't have access to that we're gonna have to make over here?

Ryan Stolley (29:03)
So from the chemical literature, you can see a variety of compounds that come from, I think it's the Shanghai Chemical Company, that are provided to these scientists to do these types of experiences that they publish on. Right. The other part of this, and this is from a company that makes chemicals, is the best stuff you don't talk about, you know what I mean? You can't put it out, because if you do, again, I can make it. Right. Like it's all the same things. And so a lot of times you don't publish your recipes or you're not saying what the best ones are. And so I know about ones that exist in the literature, like Cyanex, right? Or then CA-12 is another one that people have not been able to get their hands on. And so these are ones to look out for. And then some of these, we're trying to look for clearance of how we can produce them en masse.

Daniel O'Connor (29:56)
Ryan, it's exciting because Dustin and I speak a lot about this on our show here and with a lot of our guests. America, probably starting in the 70s, 80s, started losing its culture around production, especially manufacturing physical production, and focus more on the movement of money. Software development, technology, internet came. Then it was advanced software, now it's AI. But production is very, very important and chemistry is cool. I mean, they kind of made it cool in a bad way in this culture with Breaking Bad, for example, where a math teacher has to generate a bunch of money quickly for his family and he uses chemistry in the wrong way, but I think you're part of a revolution in this country. And that is chemists here in Salt Lake City. We can make the products that can help liberate our supply chain. I mean, a comment on that.

Ryan Stolley (31:14)
Yeah, I think about this a lot 'cause I stumbled into this position. A lot of organic chemists when you start thinking about things they want to make and the industries they want to go into, it's fine pharmaceuticals, right? Where you're selling your IP for $2 billion for your cancer medicine and now I'm working in commodity chemicals. Right. And so now it's a whole nother game in terms of we need to provide a lot of this kinds of stuff, right? And then I don't have like the pharma levels of overhead or like ability to spend that kind of money. And so the creative challenge in making things here, right, in an industry that I would say is not so sexy for other chemists. It's been very cool. And especially the very limited chemical companies within Salt Lake City without us getting too much of the homers. And so it's been actually quite nice that right, we can do some custom synthesis for people in a variety of fields.

Daniel O'Connor (32:19)
Well we're biased. I mean, when I first spoke with Brett, who's your founder, we're both from Salt Lake City, the Intermountain West, and we want to see the Intermountain West thrive. So talk about your company, and at the end of this, Dustin can ask you about how folks can get in touch with you. Dustin.

Dustin Olsen (32:47)
Ryan, a question that I've been thinking about is you're in charge of R&D at GlycoSurf, you're the principal chemist, but you're also doing a lot of work with the University of Utah and leading some research over there. What does that look like? How does both benefit from your time and talent at GlycoSurf and the U?

Ryan Stolley (33:14)
Yeah, it's cool. I'll give a little background on kind of what I'm doing at the U. I have a very interesting position here. So my official title is Associate Director for the Science Research Initiative. So the Science Research Initiative was a goal we started right when the pandemic started to get first-year college of science students into research labs. For those who did scientific research as undergrads, it's tough. Sometimes you gotta get handpicked or you gotta be brave enough to go reach out, typically in your junior senior year. If you don't have the social capital, if you don't really know what you're doing, it's kind of a competitive field and so we kind of just want to give them experience up front. Because even right, so somebody's like, I'm gonna graduate with my chemistry degree, I'm finally getting into a chemistry lab one year out, and then you realized you hate it. And like that's a tough place to be in. So when we started this, we had 30 students and we are placing them in five groups. What was nice is as a condition for me starting with this, I got to run one of these research groups. And so I got a research lab, a startup, I just had to take undergrads. I'm not a tenure track faculty, so I didn't get graduate students. And so I'm like, this is fine, we can make this work. We now have 700 students, and we are gonna place probably about 500 of them in about 80 research groups across campus. And then we have our own postdoctoral program. So now a major lift of this is we have 16 postdocs across various scientific disciplines. And so because I've been doing this so long, getting really good productivity, we publish quite a bit just with my undergrads, is I teach our postdocs how do you do science project management. How do you get freshman, sophomore students to do something that's actually gonna be useful without them having to because they're only there for a year. And so it's been really nice because now I have students in and I gotta train them. Or we do in the weeds organic chemistry, right? So we do like first principles new reaction development, they have no idea what's going on. How do I get them to come in, pick something up, put it down, know what they're doing, and be able to do it again? And so now over these seven years now, I've had a really good system in place, and so I think we've hired probably five of my ex-students into our company. Some of them have stayed on quite some time. Some realized once they got the experience they want to go back to grad school. Some it's a really good lesson, they didn't want to do chemistry anymore. That's great too. And so now we've got this kind of continuity and chain that comes through. This is like my personal view, because I get to train a student, stick with them four years, watch how they mature, coach them up, then put them into the game, right? Into the company, where now I can trust them versus say a new hire, right? Even if that new hire has maybe higher credentialing. I've known this kid for, I don't know, five years and I know what they're capable of and how I can push them through. And so it's been great. Now my more advanced students, I'm gonna be launching this pretty soon, it's gonna be a student led chemical consulting firm. So it's the molecular design studios. So we've had a really nice experience with this. We have projects that are through my lab, but if somebody wants to do, say, biochem, I now have collaboration with a biochemistry professor. We're doing synthesis. So now my student meets with her, she gives her project timelines. We even talk about what budgeting looks like all through this, and this is all student led, and it's to make compounds for other people. So we do this in biology. We do this in chemistry. I'm also adjunct faculty in physics where we're making polymers. And so now working students in where they're going for more of a mature, I can do some chemistry stuff. So now like what's work on your more project management, skills-based training, so that you can show reliability, you can show your reporting, you have a concept of budgets, and then you know it'll be more of a hardline project than us digging weeds and just trying to find new things. And so it's been pretty cool and really actually exciting for us.

Dustin Olsen (37:08)
That is actually quite cool and that you're giving them career level experience to know how to manage themselves.

Ryan Stolley (37:20)
I think about this a lot.

Dustin Olsen (37:23)
Yeah, it makes sense. So we talk to quite a few people and we hear there's just a declining interest across the board in this industry. Would you say that's coming back with the work you're doing, the way you've structured your program at the university, are people more interested in being more engaged in wanting to be chemists or is it still a fight?

Ryan Stolley (37:53)
Yeah, it's hard and it changes day to day, right? And so like you can see this just an enrollment criteria. Biology is huge. But then what's really nice and like this is my little trick with the students, is like you are a conscious sack of chemicals. It's all the same things. And so maybe you want to be a doctor, maybe you want to do biology, but like it's all chemicals moving together and interacting. So like you should probably just kind of figure out how that all works and then you can figure out all the other stuff later. The other part too, and it's like kind of tying both of these things together is the College of Science, right? So that's where we're embedded. They've recently now working together with the College of Mines and Earth Sciences, and so the mining engineering program here is now part of the College of Science, and so they're being pulled in now to our program, and we're starting to deploy these undergrads that are freshmen. Some know very much what they want to do, be doctors, and then the rest don't really know what they want to do. Mining engineering at the U didn't have the largest undergraduate cohort, but now they can get science students who aren't really sure what they're into. They started interacting with the mining engineering departments, metallurgy, and they realized like, I like chemistry. I also kind of like I don't know, geology, kind of like engineering. And so it gives them a really good opportunity to see such an interfacial department or like intersectional department where they're doing a lot of different very cool things. And so this has been really kind of fun, considering that like my hobby is this business where I stumbled into rare earths and mining and all of a sudden I get to see these people who are experts in this space. We can talk about this and now thinking about building collaborations in that space. I have our company and we're working on these things, but I'm also a chemist who's also generally excited about stuff. And so I can also look at extractants in my own personal lab for say non conflict of interest reasons, other types of elements that might be on that critical, critical list. Right. And so now we can start creating these feedback loops where I'm doing chemistry that's exciting, that I can then work with my mining and engineering colleagues, and then we can also think about how we can turn that IP into something we could use at the U, or that we could use at the company and the company would license it, and then I can teach students about licensing and IP and all kinds of fun things like this.

Daniel O'Connor (40:15)
So Ryan, let's talk about that because typically, working with the university, University of Utah is going to have its own corporate development department. They have their own policies, procedures, politics. And not that there would be politics at the U. But let us say we start defining your organization, your company, business, right? And let us say they're pretty sizable projects, maybe some development using some of your IP, using some of the company's IP. Would that be something you work with the university to marshal that through? Or like how much flexibility and leeway do you have really? Because again, universities tend to be pretty regimented about these things.

Ryan Stolley (41:14)
Yeah, I'll come out with a blanket statement saying that all the work at GlycoSurf, all that IP is owned by GlycoSurf or from other places that we're licensing from. So I'm totally separate in that entity. But with the idea is this moving forward. I'm patenting something out of my lab currently that's not related to rare earths, and we've had a few invention disclosures. And so it depends on what you want to do. They do engage in these conversations, right? And so you're not getting completely muscled out of this intellectual property. You know, you're working with the licensing office to develop kind of best laid plans, right? And so they do a really good job of like asking, are you just doing this to do it? Do you actually want to make a company out of this? And so they work with you quite a bit around what it is that they want to do with you and this stuff. Plus then they have subject matter experts who if they think this idea is gonna go gangbusters, they will really start to pick it up and drive it, right? And so, right, because if that IP is owned by the university, then it's in their best interest to push it through.

Daniel O'Connor (42:14)
Yeah. It is. I mean I've got a pretty substantial amount of experience working with universities on the biotech and pharma side. That's the background that I came out of. And it depends on the university. The U I think is pretty forward thinking and pretty entrepreneurial. Some universities can be more sort of stagnant, static. But the U, I think, is a pretty dynamic place for business, along with the Utah culture. It's a very entrepreneurial culture. Dustin, you and I have talked about that.

Ryan Stolley (42:56)
Yeah, you can see it when you look at companies that spin out of universities, they're always some of the top ranked for these types of things. I found it to be a supportive environment here. And so yeah, it's been great.

Daniel O'Connor (43:08)
Yeah. That's excellent. That's really excellent.

Ryan Stolley (43:15)
I'm just a scientist by heart and so like I think these things are cool and it's cool to start a company, but I'm really in it for the work and the game. And so it's if somebody's finding value in this and like find somebody to lead it and if I can just play around with cool chemistry and teach some students and make some cash, then that's good for me.

Daniel O'Connor (43:35)
Look, I think that we need to learn more about your company and the strengths and the marketplace and we can talk more offline but I'm really intrigued and again speaking with Brett, I found it to be fascinating that you all are right here and I think there could be some mutually beneficial opportunity. With Rare Earth Exchanges we run into a lot of opportunity because people from all over the world go to our site, engage with us, so we learn a lot.

Ryan Stolley (44:10)
For sure. You guys are more than welcome to drop by. I'll give you guys a tour. We've got a conference room. We can sit and chat about stuff too.

Daniel O'Connor (44:16)
Yeah, that would be great. Dustin, I know we're kinda coming towards the end of the hour. Any thoughts as we approach the conclusion of this really interesting episode?

Dustin Olsen (44:29)
My thoughts are that chemistry's cool. It's really fascinating, just the different things that can be done with just changing a few things and it will be interesting to see what Ryan can do with what he's doing in his lab, but also in turn at GlycoSurf and how they're gonna be able to serve the industry at large to help with the big bottleneck that we have, which is extraction and separation. That'll be really exciting once a lot of that can come online at a commercial scale.

Ryan Stolley (45:04)
Yeah. I mean, yeah, if your buddy's got deep pockets, we got IP, we can build it, right? And so that's kinda the impediment right now. I just need a factory and I can get you as much as you want.

Dustin Olsen (45:18)
Perfect. So on that note.

Daniel O'Connor (45:19)
Sign us up for Breaking Good.

Ryan Stolley (45:21)
Mm. All right. That's good.

Dustin Olsen (45:25)
Yeah. So on that note, Ryan, if people want to get in touch with you, learn more, be involved with GlycoSurf or otherwise, where should we send them?

Ryan Stolley (45:36)
Yeah, so you can go to glycosurf.com. We have our general contact information on there. You can also reach out to me. It's rstolley@glycosurf.com. I'm always on my email, happy to get back to you on all different types of things. You'll see Chett Boxley, he's our CEO and he's always happy to chat too. And we're out there too. So if you see us at conferences, at I don't know, trade shows, come say drop us a line, say that you heard from us here and we're happy to share that down the line too.

Dustin Olsen (46:07)
Perfect. Well, Ryan, hopefully we can get you back on the show again in the future, get an update with how things are progressing and the impact that you're continuing to make on the industry.

Ryan Stolley (46:18)
Yeah, that'd be great. I'd be happy to do it any time. Just let me know. Of course. Yeah, I hope you guys can come for a tour. I'd be happy to see you in person.

Daniel O'Connor (46:21)
Thank you.

Dustin Olsen (46:21)
Perfect. Well, thanks for being here, Ryan.

Spread the word:

Search
Recent Episodes

S2 E95: Rare Earth Separation Can Take 1,000 Stages. GlycoSurf Saw 5. | Ryan Stolley

S2 E94: The Rare Earth Project With No Pit and No Tailings Dam | Andrew Reid, Brazilian Critical Minerals

S2 E93: The U.S. Stopped Teaching Silicon Carbide. China Didn’t. | Josh Robinson, Penn State

S2 E92: E-Waste Is 100x Richer Than the Mine We’re Digging | Matt Bedingfield, Mint Innovation

S2 BONUS: Malaysia’s Rare Earth Carbonate Only Went to China. Until Now. | Milan Perlly, DTEC

Straight Into Your Inbox

Straight Into Your Inbox

Receive a Daily News Update Intended to Help You Keep Pace With the Rapidly Evolving REE Market.

Fantastic! Thanks for subscribing, you won't regret it.

Straight Into Your Inbox

Straight Into Your Inbox

Receive a Daily News Update Intended to Help You Keep Pace With the Rapidly Evolving REE Market.

Fantastic! Thanks for subscribing, you won't regret it.